Ignite Creation Date:
2024-05-06 @ 6:21 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05638594
Status:
RECRUITING
Last Update Posted:
2023-03-20
First Post:
2022-11-24
Brief Title:
Pyrotinib Combined With Trastuzumab Dalpiciclib Letrozole Versus TCbHP Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin as Neoadjuvant Treatment in HR HER2 Breast Cancer
Sponsor:
Organization:
Shengjing Hospital